4-Methyl-N-(pyridin-2-yl)benzenesulfonamide, 95+%, 1g

4-Bromo-3,5-dimethylanisole, 98.0%, 5g

N-methylnaphthalen-1-amine hydrochloride, 98%, 1g

(E)-3-(2-chloro-4-(ethylamino)pyrimidin-5-yl)acrylic acid, 95%, 100mg

Thiazol-5-ylmethyl ((2S,3S,5S)-5-amino-3-hydroxy-1,6-diphenylhexan-2-yl)carbamate, 95%, 5g

Prulifloxacin, >98.0%(HPLC)(T), 250mg

Manidipine Dihydrochloride>98.0%(HPLC)(T)1g

5-Methoxy-2-methylbenzo[d]thiazole, 95.0%, 5g

1-(2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-N,N-dimethylmethanamine hydrochloride, 97%, 100mg

6-Bromo-2,2-dimethylchroman-4-amine hydrochloride, 95%, 1g

Solución estándar de neodimio ICP, ROTI®Star, 250 ml, HDPE

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpent-4-ynoic acid, 95.0%, 250mg

Ethyl 3-oxooctanoate, 98+%, 1g